Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Accordance of registered drug packs with Helicobacter pylori treatment regimens (CROSBI ID 683566)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija

Rušić, Doris ; Jukić, Ivana ; Bukić, Josipa ; Leskur, Dario ; Šešelja Perišin, Ana ; Modun, Darko Accordance of registered drug packs with Helicobacter pylori treatment regimens // 9. hrvatski kongres farmakologije s međunarodnim sudjelovanjem: zbornik sažetaka. Zagreb, 2019. str. 109-109

Podaci o odgovornosti

Rušić, Doris ; Jukić, Ivana ; Bukić, Josipa ; Leskur, Dario ; Šešelja Perišin, Ana ; Modun, Darko

engleski

Accordance of registered drug packs with Helicobacter pylori treatment regimens

Introduction: In the light of the increasing antibiotic resistance several authors have raised questions about accordance of drugs packs with recommended duration of treatment in the guidelines. These have been investigated for most frequently consumed antibiotics in primary care. Considering rising prevalence of Helicobacter pylori infection, complexity of treatment regimens and a variety of treatment regimens proposed, the aim of this study was to investigate how many of the proposed regimens could be matched perfectly with drugs registered in Croatia. Materials and methods: We considered treatment regimens for. H. pylori infection proposed by the Maastricht V/Florence Consensus Report. Shortest recommended treatment duration of 10 days and longest recommended treatment duration of 14 days were considered. Drugs were identified in Croatian drug database. Metronidazole 500 mg was considered interchangeable with 400 mg metronidazole. Furthermore, doxycycline replaced tetracycline as it is not registered in Croatia. Patient adherence to the treatment was assumed to be ideal. Results: Drug packs registered in Croatia more frequently matched 10-day treatment regimens than 14 day. Sequential therapies could not be matched for 10-day duration. Rifabutin and furazolidone-based treatments were not matched due to limited availability of drugs in Croatia. None of the 14-day treatment regimens was matched. Conclusions: This study outlines poor accordance of registered antibiotics for treatment of H. pylori that results in excess units of antibiotics. Antibiotics stocked at home may be used inappropriately in the future what contributes to the emergence of antibiotic resistance.

Helicobacter pylori ; Maastricht V/Florence Consensus Report ; antibiotic resistance ; drug pack ; treatment guidelines

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

109-109.

2019.

objavljeno

Podaci o matičnoj publikaciji

9. hrvatski kongres farmakologije s međunarodnim sudjelovanjem: zbornik sažetaka

Zagreb:

Podaci o skupu

9. hrvatski kongres farmakologije = 9th Croatian Congress of Pharmacology

poster

25.09.2019-28.09.2019

Zagreb, Hrvatska

Povezanost rada

Farmacija, Kliničke medicinske znanosti